Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism
Alterations in the MAPK pathway are common in cancers, yet mutations are rarely found in patients. Here the authors find genomic amplifications of the PPP1CA gene in advanced and metastatic prostate cancer and identify a role for this phosphatase in the positive regulation of ERK signalling.
Guardado en:
Autores principales: | Ming Chen, Lixin Wan, Jiangwen Zhang, Jinfang Zhang, Lourdes Mendez, John G. Clohessy, Kelsey Berry, Joshua Victor, Qing Yin, Yuan Zhu, Wenyi Wei, Pier Paolo Pandolfi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c35271d6beb405c951ac4056c1c2de6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural basis of liprin-α-promoted LAR-RPTP clustering for modulation of phosphatase activity
por: Xingqiao Xie, et al.
Publicado: (2020) -
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer
por: Katsunori Tozuka, et al.
Publicado: (2021) -
Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity.
por: Pauline J van der Watt, et al.
Publicado: (2011) -
Antagonizing retinoic acid and FGF/MAPK pathways control posterior body patterning in the invertebrate chordate Ciona intestinalis.
por: Andrea Pasini, et al.
Publicado: (2012) -
Global patterns of phosphatase activity in natural soils
por: O. Margalef, et al.
Publicado: (2017)